Cargando…

Targeting new therapies in combination with hormonal therapies for ER-positive breast cancer

Detalles Bibliográficos
Autor principal: Dowsett, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233501/
http://dx.doi.org/10.1186/bcr1080
_version_ 1782344728377819136
author Dowsett, M
author_facet Dowsett, M
author_sort Dowsett, M
collection PubMed
description
format Online
Article
Text
id pubmed-4233501
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42335012014-11-18 Targeting new therapies in combination with hormonal therapies for ER-positive breast cancer Dowsett, M Breast Cancer Res Oral Presentation BioMed Central 2005 2005-06-17 /pmc/articles/PMC4233501/ http://dx.doi.org/10.1186/bcr1080 Text en
spellingShingle Oral Presentation
Dowsett, M
Targeting new therapies in combination with hormonal therapies for ER-positive breast cancer
title Targeting new therapies in combination with hormonal therapies for ER-positive breast cancer
title_full Targeting new therapies in combination with hormonal therapies for ER-positive breast cancer
title_fullStr Targeting new therapies in combination with hormonal therapies for ER-positive breast cancer
title_full_unstemmed Targeting new therapies in combination with hormonal therapies for ER-positive breast cancer
title_short Targeting new therapies in combination with hormonal therapies for ER-positive breast cancer
title_sort targeting new therapies in combination with hormonal therapies for er-positive breast cancer
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233501/
http://dx.doi.org/10.1186/bcr1080
work_keys_str_mv AT dowsettm targetingnewtherapiesincombinationwithhormonaltherapiesforerpositivebreastcancer